GRAIL (GRAL) Other Stockholders Equity: $0.0 Mil (As of Mar. 2026)


GRAL GRAIL Inc GRAL
12 GF Score
Price $68.11
! 2 Warning Signs
View Full Analysis

What is GRAIL Other Stockholders Equity?

GRAIL GRAL -0.23% 12 Other Stockholders Equity is $0.0 Mil as of Mar. 2026. GuruFocus rates GRAL with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

GRAIL's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $0.0 Mil.

GRAIL's quarterly Other Stockholders Equity increased from Sep. 2025 ($-0.0 Mil) to Dec. 2025 ($-0.0 Mil) and increased from Dec. 2025 ($-0.0 Mil) to Mar. 2026 ($0.0 Mil).

GRAIL's annual Other Stockholders Equity declined from Dec. 2023 ($11,421.4 Mil) to Dec. 2024 ($0.0 Mil) and declined from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($-0.0 Mil).

GRAIL Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for GRAIL's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GRAIL Other Stockholders Equity Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 10,955.91 11,421.45 0.00 -0.00

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 -0.00 0.00
GRAL
12GF Score
GRAIL Inc GRAL
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GRAIL Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.0 Mil mean?
GRAIL (GRAL) has a Other Stockholders Equity of $0.0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on GRAIL and its competitors.
Is GRAIL's Other Stockholders Equity too high?
GRAIL's current Other Stockholders Equity is $0.0 Mil. Overall, GRAIL has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does GRAIL's Other Stockholders Equity compare to ADPT and WGS?
GRAIL's Other Stockholders Equity of $0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on GRAIL and its competitors. GRAIL's current Other Stockholders Equity is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GRAIL stock overvalued right now?
GRAIL (GRAL) has a current Other Stockholders Equity of $0.0 Mil. The current Other Stockholders Equity is $0.0 Mil. GRAIL's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For GRAIL (GRAL), the current Other Stockholders Equity is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GRAIL Business Description

Other Exchanges NL0:Germany
Address 1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
12GF Score

Get the complete analysis for GRAL

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.11
Price